Drug profile · INN
migalastat hydrochloride
GALAFOLD
migalastat hydrochloride (GALAFOLD) is a alpha-galactosidase a stabiliser. Route of administration: oral. Current US regulatory status: approved.
Drug details — migalastat hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
migalastat hydrochloride (GALAFOLD) is a alpha-galactosidase a stabiliser. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Alpha-galactosidase A stabiliser
Primary target: Alpha-galactosidase A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| PMDA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is migalastat hydrochloride?
migalastat hydrochloride (GALAFOLD) is a alpha-galactosidase a stabiliser. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for migalastat hydrochloride?
GALAFOLD is a marketed brand name for migalastat hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of migalastat hydrochloride?
migalastat hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.